Stoke Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $496k | 75k | 6.65 |
| 2024-12-31 | $640k | 58k | 11.00 |
| 2024-09-30 | $316k | 26k | 12.31 |
| 2024-06-30 | $204k | 15k | 13.50 |
| 2024-03-31 | $77k | 5.5k | 14.00 |
| 2023-12-31 | $20k | 4.0k | 5.00 |
| 2023-09-30 | $2.4k | 600 | 4.00 |
| 2023-03-31 | $7.0k | 845 | 8.33 |
| 2022-12-31 | $9.6k | 1.0k | 9.23 |
| 2022-09-30 | $15k | 1.2k | 12.56 |
| 2021-12-31 | $1.3M | 55k | 24.00 |
| 2021-03-31 | $1.7M | 44k | 38.85 |
| 2020-12-31 | $243k | 3.9k | 61.96 |
| 2020-09-30 | $95k | 2.8k | 33.38 |
| 2020-06-30 | $137k | 5.7k | 23.84 |
| 2020-03-31 | $165k | 7.2k | 22.94 |
| 2019-12-31 | $124k | 4.4k | 28.23 |
| 2019-09-30 | $9.2k | 407 | 22.60 |